CAPLIPOINT

Caplin Point Laboratories Share Price

₹2,209.75 +3.5 (0.16%)

21 Jan, 2025 00:11

SIP TrendupStart SIP in CAPLIPOINT

Start SIP

Performance

  • Low
  • ₹2,166
  • High
  • ₹2,228
  • 52 Week Low
  • ₹1,225
  • 52 Week High
  • ₹2,641
  • Open Price₹2,210
  • Previous Close₹2,206
  • Volume108,370

Investment Returns

  • Over 1 Month -7.68%
  • Over 3 Month + 14.68%
  • Over 6 Month + 47.55%
  • Over 1 Year + 49.59%
SIP Lightning

Smart Investing Starts Here Start SIP with Caplin Point Laboratories for Steady Growth!

Invest Now

Caplin Point Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 34
  • PEG Ratio
  • 1.9
  • Market Cap Cr
  • 16,797
  • P/B Ratio
  • 6.6
  • Average True Range
  • 104.34
  • EPS
  • 64.93
  • Dividend Yield
  • 0.2
  • MACD Signal
  • 19.84
  • RSI
  • 39.36
  • MFI
  • 38.49

Caplin Point Laboratories Financials

Caplin Point Laboratories Technicals

EMA & SMA

Current Price
₹2,209.75
+ 3.5 (0.16%)
pointer
  • stock-down_img
  • Bearish Moving Average 11
  • stock-up_img
  • Bullish Moving Average 5
  • 20 Day
  • ₹2,357.25
  • 50 Day
  • ₹2,287.09
  • 100 Day
  • ₹2,121.24
  • 200 Day
  • ₹1,874.25

Resistance and Support

2201.18 Pivot Speed
  • R3 2,298.17
  • R2 2,262.98
  • R1 2,236.37
  • S1 2,174.57
  • S2 2,139.38
  • S3 2,112.77

What's your outlook on Caplin Point Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Caplin Point Laboratories is a rapidly growing pharmaceutical company with a strong presence in Latin America, Francophone Africa, and expanding into regulated markets like the USA and EU. it specializes in manufacturing and distributing a wide range of pharmaceutical products.

Caplin Point Labs. has an operating revenue of Rs. 1,830.78 Cr. on a trailing 12-month basis. An annual revenue growth of 16% is outstanding, Pre-tax margin of 33% is great, ROE of 20% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 25% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 84 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 49 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Caplin Point Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-07 Quarterly Results
2024-08-07 Quarterly Results & Final Dividend
2024-05-16 Audited Results & Interim Dividend
2024-02-09 Quarterly Results
2023-11-09 Quarterly Results
Date Purpose Remarks
2024-05-31 INTERIM Rs.2.50 per share(125%)Interim Dividend
2023-06-09 INTERIM Rs.2.00 per share(100%)Interim Dividend
2022-05-24 INTERIM Rs.2.00 per share(100%)Interim Dividend
2021-05-19 INTERIM Rs.1.50 per share(75%)Interim Dividend
View More

Caplin Point Laboratories F&O

Caplin Point Laboratories Shareholding Pattern

70.56%
1.62%
0.15%
3.71%
0%
17.12%
6.84%

About Caplin Point Laboratories

  • NSE Symbol
  • CAPLIPOINT
  • BSE Symbol
  • 524742
  • Managing Director
  • Dr. Sridhar Ganesan
  • ISIN
  • INE475E01026

Similar Stocks to Caplin Point Laboratories

Caplin Point Laboratories FAQs

Caplin Point Laboratories share price is ₹2,209 As on 20 January, 2025 | 23:57

The Market Cap of Caplin Point Laboratories is ₹16796.7 Cr As on 20 January, 2025 | 23:57

The P/E ratio of Caplin Point Laboratories is 34 As on 20 January, 2025 | 23:57

The PB ratio of Caplin Point Laboratories is 6.6 As on 20 January, 2025 | 23:57

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23